Rosen Law Firm Appointed as Lead Counsel in ImmunityBio Securities Class Action
The Rosen Law Firm has been appointed lead counsel for a securities class action involving ImmunityBio, Inc. The lawsuit likely stems from alleged misrepresentations or omissions related to the company's financial disclosures or business practices. Such appointments typically occur when investors believe they have suffered losses due to misleading information provided by public companies. Rosen Law Firm is known for representing shareholders in such cases and pursuing compensation on their behalf through legal action. The appointment could lead to increased scrutiny of ImmunityBio’s operations, potentially affecting its stock price as the case develops.
Tickers: $IBRX
Topics: class action lawsuit lead counsel